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ABSTRACT: A method for the hydroxylation of aryl and heteroaryl halides, promoted by a catalyst based on a biarylphosphine
ligand tBuBrettPhos (L5) and its corresponding palladium precatalyst (1), is described. The reactions allow the cross-coupling of
both potassium and cesium hydroxides with (hetero)aryl halides to aﬀord a variety of phenols and hydroxylated heteroarenes in
high to excellent yield.
Phenols, hydroxylated heteroarenes, and phenol derivatives[e.g., alkyl (hetero)aryl ethers, bi(hetero)aryl ethers]
represent important structural motifs found in natural
products,1 materials,2 pharmaceuticals,3 and agrochemicals4
(Figure 1). Furthermore, phenol subunits are common building
blocks and versatile synthetic intermediates. Phenols are
traditionally prepared by nucleophilic aromatic substitution,5
hydrolysis of arenediazonium salts (Sandmeyer reactions),6 and
deprotection of phenol precursors (e.g., ethers, esters,
carbamates),7 but these methods generally exhibit limited
substrate scope and/or may require harsh reaction conditions.
Recently, methods to generate phenols from the corresponding
boronic acids have been developed, including the oxidation of
(hetero)arylboronic acids,8 and the copper-catalyzed oxidative
cross-coupling between (hetero)arylboronic acids and hydrox-
ide ion.9 Unfortunately, these strategies may require multiple
synthetic operations, depending on the availability of the
organoboron starting materials.10 Alternatively, functionalized
phenols may be synthesized via the iridium-catalyzed C−H
activation/borylation/oxidation of arenes,11 as well as the
transition-metal-catalyzed C−H activation/oxidation of are-
nes.12 However, these methods are restricted by the C−H
activation step, which can suﬀer from a lack of regioselectivi-
ty12g,i,j or require neighboring group assistance.12a−i
The transition-metal-catalyzed cross-coupling of (hetero)aryl
halides with hydroxide salts represents a direct, convenient,
regioselective, and relatively atom-economical process to aﬀord
phenols and hydroxylated heteroarenes.13−15 The Cu-catalyzed
hydroxylation of aryl bromides and iodides has been applied to
prepare a wide range of functionalized phenols.14 These Cu-
catalyzed protocols are generally limited to the use of electron-
deﬁcient aryl chloride coupling partners;14c,g,i however, the
analogous Pd-catalyzed process is complementary in this regard
and potentially capable of transforming a broader scope of aryl
halides to phenols and derivatives thereof.15 In contrast to the
Cu-catalyzed process, the Pd-mediated aryl C−OH bond
formation had been challenging due to (1) the slow reductive
elimination of the proposed (ligand)Pd(aryl)(hydroxo) inter-
mediate15g and (2) competing arylation of the phenol product
to form the corresponding biaryl ether.15g In 2006, we reported
the Pd-catalyzed hydroxylation of (hetero)aryl halides using the
biarylphosphine ligands tBuXPhos and Me4tBuXPhos (L1 and
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Figure 1. Selected pharmaceutical and pesticide molecules containing
the phenol and hydroxylated heteroarene motifs.
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L2, Figure 2) as the supporting ligands.15a In this example, the
use of sterically bulky L1 and L2 was shown to facilitate the
selective arylation of hydroxide salts.15a Beller et al. then
reported that the use of L3 (Figure 2) promoted the Pd-
catalyzed arylation of KOH and CsOH at elevated and room
temperatures, respectively.15d,e Subsequently, Chern et al.
demonstrated a microwave-assisted hydroxylation of (hetero)-
aryl halides using a Pd catalyst based on the Herrmann−Beller
palladacycle and L1.15f More recently, Stradiotto et al. reported
the room-temperature Pd-catalyzed arylation of CsOH using
the BippyPhos ligand L4 (Figure 2).15g
We recently reported the Pd-catalyzed cross-coupling of
methanol with (hetero)aryl halides in 1,4-dioxane to aﬀord a
wide range of methyl (hetero)aryl ethers by employing a bulky
tBuBrettPhos ligand (L5)16 and its corresponding amino-
biphenyl palladacycle precatalyst 117 (Figure 2).18 We reasoned
that the same catalyst would also promote the cross-coupling of
hydroxide salts with (hetero)aryl halides. In addition, the use of
L5 as a sole ligand would be operationally more simple and
practical for hydroxylation, compared with the previous use of
the dual biarylphosphine ligands L1 and L2.15a Herein, we
report a modiﬁed Pd-catalyzed hydroxylation method of
(hetero)aryl halides, utilizing a catalyst system composed of
precatalyst 1 and L5. This alternative reaction protocol features
the use of a lower Pd-catalyst loading (2 mol %) and the
compatibility of a wider scope of heteroaryl halides as coupling
partners, compared with our previously reported protocol using
catalyst systems based on Pd2dba3 (up to 4 mol % Pd) and both
L1 and L2.15a
We began our studies by examining the reaction of 4-
chloroanisole with KOH (3 equiv) in 1,4-dioxane at 80 °C,
using a Pd catalyst based on 1 (2 mol %) and L5 (2 mol %)
(Table 1). In the presence of 20 equiv of water, the reaction
occurred smoothly to aﬀord 4-methoxyphenol (2) in 85% yield
(Table 1, entry 1). The yield of 2 was decreased when the
amount of added water was increased (Table 1, entries 2 and
3). Moreover, varying the stoichiometry of KOH also led to
lower yields of 2, as exempliﬁed in entries 4 and 5 (Table 1).
Finally, no reaction occurred at 50 °C (Table 1, entry 6).
Next, we studied the substrate scope of Pd-catalyzed
coupling of KOH with (hetero)aryl halides at 80 °C (Scheme
1).19 Both functionalized and sterically hindered aryl halides
could be coupled with KOH to aﬀord the phenols in high to
excellent yields (3a−3e). Sterically hindered bromonaphtha-
lenes were also suitable coupling partners (3f, 3g), and a variety
of heteroaryl halides could be converted to the corresponding
hydroxylated heteroarenes, including quinoxalines (3h), indoles
(3i), benzothiophenes (3j), benzofurans (3k), benzo-2,1,3-
thiadiazoles (3l), and dibenzothiophenes (3m). Further, the
ﬁve-membered heterocyclic portion of 3-chloroindazole (3n)
was cleanly hydroxylated to provide 3-hydroxyindazole.
We also examined conditions to eﬀect the Pd-catalyzed
hydroxylation of aryl halides at ambient conditions. Initial
studies focused on the cross-coupling of the test substrate 1-
bromo-2,4-dimethylbenzene with CsOH (3 equiv) at room
temperature (Table 2), utilizing precatalyst 1 (2 mol %) and
ligand L5 (2 mol %). Under these conditions, we found that the
addition of 10 equiv of water led to complete conversion of the
substrate to provide 2,4-dimethylphenol (4) in the highest yield
(Table 2, entry 2). Of note, the use of THF instead of 1,4-
dioxane as solvent did not further improve the yield of 4 even
though extra water (10 equiv) was added (Table 2, entries 5
and 6). As depicted in Scheme 2, the coupling of both electron-
rich and electron-deﬁcient aryl bromides as well as sterically
hindered aryl bromides with CsOH could be achieved at
ambient temperature.20 A base-sensitive carbonyl and nitrile
group were also well-tolerated under the reaction conditions
(5b, 5f, Scheme 2).
Figure 2. Bi(hetero)arylphosphine ligands employed for Pd-catalyzed
hydroxylation of (hetero)aryl halides.
Table 1. Optimization of Pd-Catalyzed Arylation of KOHa
entry temp (°C) KOH (equiv) H2O (equiv) conv. (%)
b yield of 2 (%)b
1 80 3 20 100 85
2 80 3 40 100 76
3 80 3 111c 99 76
4 80 4 20 100 79
5 80 2 20 100 61
6 50 3 20 2 0
aReaction conditions: 4-chloroanisole (0.25 mmol), KOH (2−4 equiv), H2O (20−111 equiv), 1 (2 mol %), L5 (2 mol %), 1,4-dioxane (0.5 mL),
50−80 °C, 20 h; trace amounts of anisole and biaryl ether were detected by GCMS. bDetermined by GC. cVolume ratio of 1,4-dioxane to water =
1:1.
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In conclusion, we have developed an alternative system to eﬀect
the Pd-catalyzed hydroxylation of a variety of aryl and
heteroaryl halides using a catalyst derived from commercially
available 1 and L5. We anticipate that this catalyst will ﬁnd use
in a variety of settings in which the synthesis of phenols and
hydroxylated heteroarenes is desired.
■ EXPERIMENTAL SECTION
General Information. Nuclear magnetic resonance spectra were
recorded on a 400 MHz NMR instrument at rt. All 1H NMR spectra
were measured in parts per million (ppm) relative to the signals for
residual DMSO in DMSO-d6 (2.50 ppm).
21 Data for 1H NMR were
reported as follows: chemical shift, multiplicity (s = singlet, d =
doublet, t = triplet, q = quartet, qu = quintet, sex = sextet, m =
multiplet, ovrlp = overlap, br = broad), coupling constants, and
integration. All 13C NMR spectra were reported in ppm relative to
DMSO-d6 (39.52 ppm).
21 All commercial materials were used as
received unless otherwise noted. tBuBrettPhos (L5),16 Pd precatalyst
1,17 and 3-chloro-1-trityl-indazole (S1)18 were prepared according to
the literature procedures.
Preparation of Standard Cesium Hydroxide Solution: (i)
Mole Ratio of CsOH to H2O = 3:10. In a nitrogen-ﬁlled glovebox, an
oven-dried 25 mL round-bottom ﬂask (A) capped with a rubber
septum was charged with CsOH·H2O (16.7 g, 99.5 mmol). The ﬂask
was then evacuated and backﬁlled with argon (this process was
repeated a total of three times), and degassed deionized water (4.17
mL, 232 mmol) was then added into the ﬂask. The resulting reaction
mixture was agitated until all CsOH·H2O dissolved to form a
homogeneous solution. The bulk solution was kept under an argon
atmosphere. The mole ratio of CsOH and H2O in the standard CsOH
solution is 99.5 mmol: [232 mmol (from water added) + 99.5 mmol
(from CsOH·H2O)] = 99.5 mmol: 331.5 mmol = 3:10 (or 1:3.33).
Thus, the mole ratio of CsOH to water in the standard CsOH solution
is always kept at 3:10 for simultaneous transfers of both CsOH and
water in a desired mole ratio.
(ii) Mole Ratio of CsOH to H2O = 3:20. Following the procedure of
(i), the standard CsOH solution (mole ratio of CsOH:H2O = 3:20)
was prepared using CsOH·H2O (520 mg, 3.1 mmol) and deionized
water (0.32 mL, 17.8 mmol).
(iii) Mole Ratio of CsOH to H2O = 3:30. Following the procedure of
(i), the standard CsOH solution (mole ratio of CsOH:H2O = 3:30)
was prepared using CsOH·H2O (520 mg, 3.1 mmol) and deionized
water (0.50 mL, 27.8 mmol).
Scheme 1. Scope of Pd-Catalyzed Arylation of KOHa
aReaction conditions: (Het)ArX (1 mmol), KOH (3 mmol), H2O (20
mmol), 1 (2 mol %), L5 (2 mol %), 1,4-dioxane (2 mL), 80 °C, 18 h.
b100 °C.
Table 2. Optimization of Pd-Catalyzed Arylation of CsOH at
Room Temperaturea
entry H2O (equiv) solvent conv. (%)
b yield of 4 (%)b
1 1c 1,4-dioxane 18 8
2 10 1,4-dioxane 100 96
3 20 1,4-dioxane 93 89
4 30 1,4-dioxane 57 53
5 1c THF 28 20
6 10 THF 60 51
aReaction conditions: 1-bromo-2,4-dimethylbenzene (0.25 mmol),
CsOH (0.75 mmol), H2O (1−30 equiv), 1 (2 mol %), L5 (2 mol %),
solvent (0.5 mL), rt, 20 h; trace amounts of anisole and biaryl ether
were detected by GCMS. bDetermined by GC. cThe water was from
CsOH·H2O; no extra water was added.
Scheme 2. Scope of Pd-Catalyzed Arylation of CsOH at
Room Temperaturea
aReaction conditions: ArBr (1 mmol), CsOH (3 mmol), H2O (10
mmol), 1 (2 mol %), L5 (2 mol %), 1,4-dioxane (2 mL), rt, 18 h.
bVolatile compound; the GC yield was 96% with 0.25 mmol ArBr. c1
(3 mol %) and L5 (3 mol %). dArBr (2 mmol), CsOH (6 mmol), H2O
(20 mmol), 1 (4 mol %), L5 (4 mol %), and 1,4-dioxane (4 mL).
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Optimization of Pd-Catalyzed Arylation of KOH (Table 1). An
oven-dried 10 mL resealable screw-cap test tube (A) equipped with a
Teﬂon-coated magnetic stir bar was charged with L5 (2.4 mg, 0.005
mmol, 2 mol %) and KOH (2−4 equiv, 28.1−56.1 mg). Tube A was
evacuated and backﬁlled with argon (this process was repeated a total
of three times), and 4-chloroanisole (36 mg, 31 μL, 0.25 mmol, 1
equiv) and degassed deionized water (20−111 equiv, 90 μL to 0.50
mL) were then added into tube A via syringe. A second oven-dried 10
mL resealable screw-cap test tube (B) equipped with a Teﬂon-coated
magnetic stir bar was charged with 1 (4.3 mg, 0.005 mmol, 2 mol %).
Tube B was then evacuated and backﬁlled with argon (this process was
repeated a total of three times), and 1,4-dioxane (0.50 mL) was added
into tube B via syringe. The reaction mixture in tube B was stirred at rt
for ∼1 min to form a homogeneous solution. The precatalyst solution
from tube B was transferred into tube A via syringe. The resulting
reaction mixture in tube A was stirred at 50 or 80 °C in an oil bath for
20 h. After cooling to rt, the crude product was diluted with EtOAc (2
mL), 1,4-dimethoxybenzene (34.6 mg, 0.25 mmol, 1.0 equiv) was
added, and the mixture was then acidiﬁed with aqueous HCl solution
(1 M, 2 mL). The resulting reaction mixture in the capped test tube
was agitated until all of the solid was dissolved into the reaction
mixture. The reaction mixture was then neutralized with saturated
NaHCO3 solution (2 mL). A small fraction of the upper organic layer
was ﬁltered through a plug of silica gel and then subjected to GC
analysis to determine the reaction conversion and the GC yields of
product and 4-methoxyphenol, using 1,4-dimethoxybenzene as an
internal standard.
Optimization of Pd-Catalyzed Arylation of CsOH (Table 2).
An oven-dried 10 mL resealable screw-cap test tube (A) equipped with
a Teﬂon-coated magnetic stir bar was charged with L5 (2.4 mg, 0.005
mmol, 2 mol %) [except for Table 2, entries 1 and 5, in which the tube
was then transferred into the N2-ﬁlled glovebox, and CsOH·H2O (126
mg, 0.75 mmol, 3 equiv) was added]. Tube A was evacuated and
backﬁlled with argon (this process was repeated a total of three times),
and 1-bromo-2,4-dimethylbenzene (46.3 mg, 34 μL, 0.25 mmol) and
standard aqueous CsOH solution prepared in the preceding
procedures were then added into tube A via syringe (except for
Table 2, entries 1 and 5) [For Table 2, entries 2 and 6: CsOH:H2O =
3 equiv:10 equiv; CsOH (112.4 mg, 0.75 mmol, 3 equiv) dissolved in
deionized water (45 mg, 2.5 mmol, 10 equiv). For Table 2, entry 3:
CsOH:H2O = 3 equiv:20 equiv; CsOH (112.4 mg, 0.75 mmol, 3
equiv) dissolved in deionized water (90 mg, 5.0 mmol, 20 equiv). For
Table 2, entry 4: CsOH:H2O = 3 equiv:30 equiv; CsOH (112.4 mg,
0.75 mmol, 3 equiv) dissolved in deionized water (135 mg, 7.5 mmol,
30 equiv)]. A second oven-dried 10 mL resealable screw-cap test tube
(B) equipped with a Teﬂon-coated magnetic stir bar was charged with
1 (4.3 mg, 0.005 mmol, 2 mol %). Tube B was then evacuated and
backﬁlled with argon (this process was repeated a total of three times),
and the solvent (1,4-dioxane or THF, 0.50 mL) was added into tube B
via syringe. The reaction mixture in tube B was stirred at rt for ∼1 min
to form a homogeneous solution. The precatalyst solution from tube B
was transferred into tube A via syringe. The resulting reaction mixture
in tube A was stirred at rt for 20 h. The crude product was diluted with
EtOAc (2 mL), 1,3,5-trimethoxybenzene (42.1 mg, 0.25 mmol, 1.0
equiv) was added, and the mixture was then acidiﬁed with aqueous
HCl solution (1 M, 2 mL). The resulting reaction mixture in the
capped test tube was agitated until all of the solid was dissolved. The
reaction mixture was then neutralized with saturated NaHCO3
solution (2 mL). A small fraction of the upper organic layer was
ﬁltered through a plug of silica gel and then subjected to GC analysis
to determine the reaction conversion and the GC yields of product
and 2,4-dimethylphenol, using 1,3,5-trimethoxybenzene as an internal
standard.
Substrate Scope for the Pd-Catalyzed Hydroxylation of
(Hetero)aryl Halides. General Procedure A. An oven-dried 20 mL
resealable screw-cap test tube (A) equipped with a Teﬂon-coated
magnetic stir bar was charged with L5 (9.7 mg, 0.020 mmol, 2 mol %),
KOH (168.3 mg, 3.0 mmol, 3 equiv), and (hetero)aryl halide (if solid)
(1.0 mmol, 1 equiv). Tube A was evacuated and backﬁlled with argon
(this process was repeated a total of three times), and degassed
deionized water (0.36 mL, 20.0 mmol, 20 equiv) and (hetero)aryl
halide (if liquid) (1.0 mmol, 1 equiv) were then added into tube A via
syringe. A second oven-dried 10 mL resealable screw-cap test tube (B)
equipped with a Teﬂon-coated magnetic stir bar was charged with 1
(17.1 mg, 0.020 mmol, 2 mol %). Tube B was then evacuated and
backﬁlled with argon (this process was repeated a total of three times),
and 1,4-dioxane (2.0 mL) was added into tube B via syringe. The
reaction mixture in tube B was stirred at rt for ∼1 min to form a
homogeneous solution. The precatalyst solution from tube B was
transferred into tube A via syringe. The resulting reaction mixture in
tube A was stirred at 80 °C in an oil bath for 18 h. After cooling to rt,
the crude product was diluted with EtOAc (5 mL) and then acidiﬁed
with aqueous HCl solution (1 M, 5 mL). The resulting reaction
mixture in the capped test tube was agitated until all of the solid was
dissolved. The reaction mixture was transferred into a separatory
funnel and then neutralized with saturated NaHCO3 solution (5 mL).
The organic fraction was isolated, and the aqueous fraction was rinsed
with EtOAc (2 × 10 mL). The combined organic fractions were
concentrated in vacuo. The crude product residue was puriﬁed by ﬂash
chromatography using a solvent mixture (EtOAc/hexanes/methanol)
as an eluent to aﬀord the isolated product. The reported yields are of
the isolated product and averages of two runs.
General Procedure B. An oven-dried 20 mL resealable screw-cap
test tube (A) equipped with a Teﬂon-coated magnetic stir bar was
charged with L5 (9.7 mg, 0.020 mmol, 2 mol %) and (hetero)aryl
halide (if solid) (1.0 mmol, 1 equiv). Tube A was evacuated and
backﬁlled with argon (this process was repeated a total of three times),
and standard aqueous CsOH solution [mole ratio of CsOH to H2O =
3:10; CsOH (450 mg, 3.0 mmol, 3 equiv) dissolved in deionized water
(180 mg, 10.0 mmol, 10 equiv) as prepared in the preceding
procedures] was then added into tube A via syringe, followed by the
addition of (hetero)aryl halide (if liquid) (1.0 mmol, 1 equiv). A
second oven-dried 10 mL resealable screw-cap test tube (B) equipped
with a Teﬂon-coated magnetic stir bar was charged with 1 (17.1 mg,
0.020 mmol, 2 mol %). Tube B was then evacuated and backﬁlled with
argon (this process was repeated a total of three times), and 1,4-
dioxane (2.0 mL) was added into tube B via syringe. The reaction
mixture in tube B was stirred at rt for ∼1 min to form a homogeneous
solution. The precatalyst solution from tube B was transferred into
tube A via syringe. The resulting reaction mixture in tube A was stirred
at rt for 18 h. The crude product was diluted with EtOAc (5 mL) and
then acidiﬁed with aqueous HCl solution (1 M, 5 mL). The resulting
reaction mixture in the capped test tube was agitated until all of the
solid was dissolved. The reaction mixture was transferred into a
separatory funnel and then neutralized with saturated NaHCO3
solution (5 mL). The organic fraction was isolated, and the aqueous
fraction was rinsed with EtOAc (2 × 10 mL). The combined organic
fractions were concentrated in vacuo. The crude product residue was
puriﬁed by ﬂash chromatography using a solvent mixture (EtOAc/
hexanes) as an eluent to aﬀord the isolated product. The reported
yields are of the isolated product and averages of two runs.
10-n-Butyl-2-hydroxyacridin-9(10H)-one (3a). Following gen-
eral procedure A, the title compound was prepared using 10-n-butyl-2-
chloroacridin-9(10H)-one (286 mg, 1.0 mmol); EtOAc/hexanes (1:3),
then EtOAc; 263 mg, 98%; sunset-yellow solid. m.p.: 239−240 °C. 1H
NMR (400 MHz, DMSO-d6) δ: 9.70 (br s, 1 H), 8.32 (dd, J = 8.6 Hz,
J = 1.2 Hz, 1 H), 7.78−7.71 (ovrlp, 3 H), 7.70 (d, J = 4.0 Hz, 1 H),
7.35 (dd, J = 9.2 Hz, J = 2.8 Hz, 1 H), 7.25 (ddd, J = 8.0 Hz, J = 6.0
Hz, J = 1.6 Hz, 1 H), 4.41 (t, J = 7.6 Hz, 2 H), 1.74 (qu, J = 7.6 Hz, 2
H), 1.49 (sex, J = 7.6 Hz, 2 H), 0.96 (t, J = 7.6 Hz, 3 H). 13C NMR
(100 MHz, DMSO-d6) δ: 175.9, 152.0, 141.0, 135.2, 133.7, 126.7,
124.1, 122.8, 120.6, 120.4, 117.5, 115.5, 109.2, 45.0, 29.1, 19.4, 13.7.
Anal. Calcd for C17H17NO2: C, 76.38; H, 6.41. Found: C, 76.09; H,
6.31. IR (neat cm−1) 3278, 1591, 1568, 1499, 1460, 1357, 1270, 1229,
1171, 861, 810, 752, 684, 638.
2-Hydroxy-9H-thioxanthen-9-one (3b).22 Following general
procedure A, the title compound was prepared using 2-chloro-9H-
thioxanthen-9-one (247 mg, 1.0 mmol); EtOAc/hexanes (1:4), then
EtOAc; 224 mg, 98%; sunset-yellow solid. m.p.: 247−248 °C. 1H
NMR (400 MHz, DMSO-d6) δ: 10.16 (br s, 1 H), 8.45 (dd, J = 8.4
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Hz, J = 1.2 Hz, 1 H), 7.86 (d, J = 2.8 Hz, 1 H), 7.79 (dd, J = 8.0 Hz, J
= 0.8 Hz, 1 H), 7.73 (ddd, J = 8.4 Hz, J = 6.8 Hz, J = 1.6 Hz, 1 H),
7.67 (d, J = 8.8 Hz, 1 H), 7.54 (ddd, J = 8.4 Hz, J = 7.2 Hz, J = 1.2 Hz,
1 H), 7.27 (dd, J = 8.8 Hz, J = 2.8 Hz, 1 H). 13C NMR (100 MHz,
DMSO-d6) δ: 178.6, 156.5, 137.0, 132.6, 129.6, 129.0, 128.0, 127.7,
126.5, 126.3, 126.1, 122.7, 113.2. Anal. Calcd for C13H8O2S: C, 68.40;
H, 3.53. Found: C, 68.14; H, 3.55. IR (neat cm−1) 3303, 1620, 1568,
1484, 1436, 1341, 1216, 1150, 1121, 1075, 814, 736, 633.
4-(Benzothiazol-2-yl)phenol (3c).23 Following general proce-
dure A, the title compound was prepared using 2-(4-chlorophenyl)-
benzothiazole (246 mg, 1.0 mmol); EtOAc/hexanes (1:6), then (1:4);
223 mg, 98%; pale-yellow solid. m.p.: 227−229 °C (lit: 228−229
°C).23 1H NMR (400 MHz, DMSO-d6) δ: 10.23 (br s, 1 H), 8.05 (dd,
J = 7.6 Hz, 1 H), 7.98 (dd, J = 8.0 Hz, 1 H), 7.93 (d, J = 8.4 Hz, 2 H),
7.49 (td, J = 8.0 Hz, J = 1.2 Hz, 1 H), 7.39 (td, J = 8.0 Hz, J = 1.2 Hz, 1
H), 6.94 (d, J = 8.8 Hz, 2 H). 13C NMR (100 MHz, DMSO-d6) δ:
167.5, 160.6, 153.7, 134.1, 129.1, 126.4, 124.9, 124.1, 122.3, 122.1,
116.1. Anal. Calcd for C13H9NOS: C, 68.70; H, 3.99. Found: C, 68.83
H, 4.13. IR (neat cm−1) 1604, 1480, 1429, 1283, 1224, 1167, 977, 826,
756, 723.
4-Methoxy-2,5-dimethylphenol (3d).24 Following general
procedure A, the title compound was prepared using 1-bromo-4-
methoxy-2,5-dimethylbenzene (215.1 mg, 1.0 mmol); EtOAc/hexanes
(1:6); 127 mg, 83%; white solid. m.p.: 89−90 °C (lit: 86−88 °C).24
1H NMR (400 MHz, DMSO-d6) δ: 8.58 (br s, 1 H), 6.62 (s, 1 H),
6.55 (s, 1 H), 3.66 (s, 3 H), 2.08 (s, 3 H), 2.03 (s, 3 H). 13C NMR
(100 MHz, DMSO-d6) δ: 150.0, 148.5, 123.1, 121.1, 117.1, 113.1,
55.6, 16.0, 15.7. HRMS (ESI) Calcd for C9H13O2 [M + H]: 153.0910.
Found: 153.0915. IR (neat cm−1) 3238, 1519, 1452, 1412, 1198, 1103,
1018, 864, 834, 671.
2,6-Dimethoxyphenol (3e).8e Following general procedure A,
the title compound was prepared using 2-bromo-1,3-dimethoxyben-
zene (217 mg, 1.0 mmol); EtOAc/hexanes (1:6), then (1:4); 134 mg,
86%; pale-brown solid. m.p.: 56−57 °C (lit: 54−56 °C).25 1H NMR
(400 MHz, DMSO-d6) δ: 8.25 (br s, 1 H), 6.69 (t, J = 8.4 Hz, 1 H),
6.59 (d, J = 8.4 Hz, 2 H), 3.74 (s, 6 H). 13C NMR (100 MHz, DMSO-
d6) δ: 148.2, 135.7, 118.1, 105.7, 55.9. HRMS (ESI) Calcd for
C8H11O3 [M + H]: 155.0703. Found: 155.0706. IR (neat cm
−1) 3452,
1612, 1508, 1478, 1438, 1360, 1279, 1210, 1097, 1027, 825, 767, 726,
706, 609.
Naphthalen-1-ol (3f).8c Following general procedure A, the title
compound was prepared using 1-bromonaphthalene (207 mg, 1.0
mmol); EtOAc/hexanes (1:6); 133 mg, 92%; pale-brown solid. m.p.:
95 °C (lit: 91−93 °C).8c 1H NMR (400 MHz, DMSO-d6) δ: 10.10 (br
s, 1 H), 8.14 (dd, J = 7.2 Hz, J = 1.2 Hz, 1 H), 7.80 (dd, J = 7.2 Hz, J =
1.6 Hz, 1 H), 7.48−7.41 (ovrlp, 2 H), 7.34−7.28 (ovrlp, 2 H), 6.88
(dd, J = 7.2 Hz, J = 1.6 Hz, 1 H). 13C NMR (100 MHz, DMSO-d6) δ:
153.2, 134.4, 127.4, 126.4, 126.1, 124.6, 124.5, 122.0, 118.3, 108.0.
HRMS (ESI) Calcd for C10H9O [M + H]: 145.0648. Found:
145.0646. IR (neat cm−1) 3277, 1598, 1457, 1385, 1268, 1148, 1083,
1043, 1015, 876, 860, 789, 764, 710.
2,3-Dimethoxynaphthalen-1-ol (3g). Following general proce-
dure A, the title compound was prepared using 1-bromo-2,3-
dimethoxynaphthalene (267 mg, 1.0 mmol); EtOAc/hexanes (1:6);
202 mg, 99%; yellow oil. 1H NMR (400 MHz, DMSO-d6) δ: 9.53 (br
s, 1 H), 8.01 (d, J = 8.4 Hz, 1 H), 7.69 (d, J = 8.0 Hz, 1 H), 7.35 (ddd,
J = 8.0 Hz, J = 6.8 Hz, J = 1.2 Hz, 1 H), 7.28 (ddd, J = 8.4 Hz, J = 6.8
Hz, J = 1.2 Hz, 1 H), 6.87 (s, 1 H), 3.89 (s, 3 H), 3.77 (s, 3 H). 13C
NMR (100 MHz, DMSO-d6) δ: 152.7, 144.6, 133.8, 130.7, 126.3,
125.5, 122.5, 121.6, 121.1, 98.2, 60.5, 55.5. HRMS (ESI) Calcd for
C12H13O3 [M + H]: 205.0859. Found: 205.0852. IR (neat cm
−1) 3500,
1739, 1635, 1600, 1509, 1476, 1295, 1265, 1231, 1195, 1120, 1095,
1032, 1015, 975, 859, 812, 735, 700.
Quinoxalin-6-ol (3h).15f Following general procedure A, the title
compound was prepared using 6-bromoquinoxaline (209 mg, 1.0
mmol); EtOAc/MeOH (20:1); 130.5 mg, 89%; brown solid. m.p.:
251−253 °C (lit: 252−254 °C).26 1H NMR (400 MHz, DMSO-d6) δ:
10.53 (br s, 1 H), 8.77 (d, J = 2.0 Hz, 1 H), 8.68 (d, J = 1.6 Hz, 1 H),
7.93 (d, J = 9.2 Hz, 1 H), 7.41 (dd, J = 9.2 Hz, J = 2.8 Hz, 1 H), 7.27
(d, J = 2.8 Hz, 1 H). 13C NMR (100 MHz, DMSO-d6) δ: 158.8, 145.4,
144.0, 142.2, 137.6, 130.4, 122.9, 109.5. Anal. Calcd for C8H6N2O: C,
65.75; H, 4.14. Found: C, 65.63; H, 4.12. HRMS (ESI) Calcd for
C8H7N2O [M + H]: 147.0553. Found: 147.0548. IR (neat cm
−1)
1610, 1478, 1409, 1304, 1231, 1197, 1117, 1036, 941, 831, 750.
1-Benzyl-1H-indol-6-ol (3i). Following general procedure A, the
title compound was prepared using 1-benzyl-6-chloro-1H-indole (241
mg, 1.0 mmol); EtOAc/hexanes (1:4); 182.1 mg, 82%; pale-brown
solid. 1H NMR (400 MHz, DMSO-d6) δ: 8.99 (br s, 1 H), 7.35 (d, J =
8.4 Hz, 1 H), 7.30 (t, J = 7.2 Hz, 2 H), 7.26 (d, J = 3.2 Hz, 1 H), 7.24
(t, J = 7.2 Hz, 1 H), 7.15 (d, J = Hz, 2 H), 6.73 (d, J = 2.0 Hz, 1 H),
6.60 (dd, J = 8.4 Hz, J = 2.0 Hz, 1 H), 6.36 (dd, J = 3.2 Hz, J = 0.4 Hz,
1 H), 5.29 (s, 2 H). 13C NMR (100 MHz, DMSO-d6) δ: 153.2, 138.4,
136.9, 128.5, 127.3, 127.2, 126.8, 121.6, 120.9, 109.7, 100.8, 95.4, 49.1.
m.p.: 103−104 °C. HRMS (ESI) Calcd for C15H12NO [M − H]:
222.0924. Found: 222.0941. IR (neat cm−1) 3308, 1625, 1580, 1507,
1468, 1354, 1321, 1267, 1168, 1074, 943, 827, 799, 745, 705.
Benzothiophen-5-ol (3j).27 Following general procedure A, the
title compound was prepared using 5-chlorobenzothiophene (169 mg,
1.0 mmol) at 100 °C; EtOAc/hexanes (1:6); 143.6 mg, 96%; oﬀ-white
solid. 1H NMR (400 MHz, DMSO-d6) δ: 9.42 (br s, 1 H), 7.74 (d, J =
8.8 Hz, 1 H), 7.65 (d, J = 5.6 Hz, 1 H), 7.27 (dd, J = 5.6 Hz, J = 0.4
Hz, 1 H), 7.21 (d, J = 2.0 Hz, 1 H), 6.88 (ddd, J = 8.4 Hz, J = 2.0 Hz, J
= 0.4 Hz, 1 H). 13C NMR (100 MHz, DMSO-d6) δ: 154.9, 140.9,
129.4, 128.0, 123.5, 123.1, 114.8, 108.2. m.p.: 105−106 °C (lit: 103−
105 °C).28 HRMS (ESI) Calcd for C8H6OS [M]: 150.0134. Found:
150.0133. IR (neat cm−1) 3235, 1599, 1565, 1502, 1422, 1231, 1149,
945, 889, 849, 748, 692.
Benzofuran-7-ol (3k).29 Following general procedure A, the title
compound was prepared using 7-chlorobenzofuran (153 mg, 1.0
mmol); EtOAc/hexanes (1:4); 125 mg, 93%; pale-yellow oil. 1H NMR
(400 MHz, DMSO-d6) δ: 9.96 (br s, 1 H), 7.91 (d, J = 2.0 Hz, 1 H),
7.06 (d, J = 7.6 Hz, 1 H), 7.02 (t, J = 7.6 Hz, 1 H), 6.87 (d, J = 2.0 Hz,
1 H), 6.74 (d, J = 7.6 Hz, 1 H). 13C NMR (100 MHz, DMSO-d6) δ:
145.4, 143.4, 142.8, 129.1, 123.5, 111.6, 110.3, 107.0. HRMS (ESI)
Calcd for C8H7O2 [M + H]: 135.0441. Found: 135.0440. IR (neat
cm−1) 3323, 1593, 1443, 1297, 1217, 1122, 841.
Benzo-2,1,3-thiadiazol-5-ol (3l). Following general procedure A,
the title compound was prepared using 5-chlorobenzo-2-1-3-
thiadiazole (171 mg, 1.0 mmol); EtOAc/hexanes (1:6); 145 mg,
95%; pale-yellow solid. 1H NMR (400 MHz, DMSO-d6) δ: 10.55 (br s,
1 H), 7.90 (d, J = 9.2 Hz, 1 H), 7.33 (dd, J = 9.2 Hz, J = 2.4 Hz, 1 H),
7.15 (dd, J = 2.4 Hz, J = 0.4 Hz, 1 H). 13C NMR (100 MHz, DMSO-
d6) δ: 159.3, 156.0, 150.1, 125.2, 121.5, 100.4. m.p.: 161−162 °C.
HRMS (ESI) Calcd for C6H5N2OS [M + H]: 153.0117. Found:
153.0114. IR (neat cm−1) 3133, 1613, 1495, 1403, 1226, 1187, 1127,
874, 833, 814, 753, 664, 626.
Dibenzothiophen-2-ol (3m).30 Following general procedure A,
the title compound was prepared using 2-bromodibenzothiophene
(263 mg, 1.0 mmol). After work up, the crude product was puriﬁed by
ﬂash chromatography using EtOAc/hexanes (1:6) as an eluent to
aﬀord dibenzothiophen-2-ol (3m) (185 mg, 92%) as a pale-brown
solid. 1H NMR (400 MHz, DMSO-d6) δ: 9.68 (br s, 1 H), 8.23−8.18
(m, 1 H), 7.97−7.91 (m, 1 H), 7.78 (d, J = 8.8 Hz, 1 H), 7.68 (d, J =
2.4 Hz, 1 H), 7.49−7.42 (ovrlp, 2 H), 7.03 (dd, J = 8.4 Hz, J = 2.4 Hz,
1 H). 13C NMR (100 MHz, DMSO-d6) δ: 155.4, 139.7, 136.3, 135.0,
128.5, 126.8, 124.4, 123.6, 123.0, 121.9, 116.7, 107.4. m.p.: 156−157
°C (lit: 158 °C).31 Anal. Calcd for C12H8OS: C, 71.97; H, 4.03.
Found: C, 71.73; H, 4.04. IR (neat cm−1) 3385, 1602, 1470, 1427,
1336, 1187, 849, 810, 755, 733.
1-Trityl-1H-indazol-3-ol (3n). Following general procedure A, the
title compound was prepared using 3-chloro-1-trityl-1H-indazole (S1)
(395 mg, 1.0 mmol); EtOAc/hexanes (1:6); 297 mg, 0.79 mmol, 79%;
pale-brown solid. m.p.: 196−197 °C. 1H NMR (400 MHz, DMSO-d6)
δ: 10.98 (s, 1 H), 7.58 (d, J = 8.0 Hz, 1 H), 7.36 (d, J = 7.2 Hz, 6 H),
7.28 (t, J = 7.2 Hz, 6 H), 7.22 (t, J = 7.2 Hz, 3 H), 7.00 (t, J = 7.2 Hz, 1
H), 6.93 (t, J = 7.2 Hz, 1 H), 6.40 (d, J = 8.4 Hz, 1 H). 13C NMR (100
MHz, DMSO-d6) δ: 144.9, 133.2, 132.7, 119.2, 117.6, 116.9, 116.3,
110.1, 109.5, 105.8, 103.6, 67.0. HRMS (ESI) Calcd for C26H19N2O
[M − H]: 375.1503. Found: 375.1507. IR (neat cm−1) 1671, 1489,
1450, 1217, 1001, 906, 746, 705, 632.
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2,4-Dimethylphenol (5a).32 Following general procedure B, the
title compound was prepared using 1-bromo-2,4-dimethylbenzene
(185 mg, 1.0 mmol); EtOAc/hexanes (1:6); 87 mg, 71%); volatile,
pale-brown oil. The 1H NMR yield of the title product was determined
to be 96% based on 0.25 mmol ArBr. 1H NMR (400 MHz, DMSO-d6)
δ: 8.93 (br s, 1 H), 6.84 (s, 1 H), 6.76 (dd, J = 8.0 Hz, J = 1.6 Hz, 1
H), 6.64 (d, J = 8.0 Hz, 1 H), 2.15 (s, 3 H), 2.07 (s, 3 H). 13C NMR
(100 MHz, DMSO-d6) δ: 153.0, 131.1, 127.0, 126.8, 123.4, 114.4,
20.1, 15.9. HRMS (ESI) Calcd for C8H10O [M]: 122.0726. Found:
122.0725. IR (neat cm−1) 3377, 2921, 1506, 1325, 1262, 1204, 1117,
929, 808, 766.
3′-Hydroxy-4′-methylacetophenone (5b).33 Following general
procedure B, the title compound was prepared using 3′-bromo-4′-
methylacetophenone (213 mg, 1.0 mmol). EtOAc/hexanes (1:2); 150
mg, 100%; oﬀ-white solid. m.p.: 121−122 °C (lit: 119−120 °C).33 1H
NMR (400 MHz, DMSO-d6) δ: 9.68 (br s, 1 H), 7.34−7.32 (ovrlp, 2
H), 7.18 (d, J = 8.0 Hz, 1 H), 2.48 (s, 3 H), 2.17 (s, 3 H). 13C NMR
(100 MHz, DMSO-d6) δ: 197.4, 155.5, 135.9, 130.7, 130.3, 119.6,
113.2, 26.5, 16.2. HRMS (ESI) Calcd for C9H11O2 [M + H]:
151.0754. Found: 151.0752. IR (neat cm−1) 3404, 1659, 1580, 1418,
1349, 1285, 1238, 1129, 899, 884, 813, 712, 688, 608.
3,4,5-Trimethoxyphenol (5c).34 Following general procedure B,
the title compound was prepared using 5-bromo-1,2,3-trimethox-
ybenzene (247 mg, 1.0 mmol), 1 (25.7 mg, 0.03 mmol, 3 mol %), and
L5 (14.6 mg, 0.03 mmol, 3 mol %); EtOAc/hexanes (1:1); 168 mg,
91%; pale-brown solid. m.p.: 147−148 °C (lit: 146−147 °C).20 1H
NMR (400 MHz, DMSO-d6) δ: 9.19 (br s, 1 H), 6.05 (s, 2 H), 3.69 (s,
6 H), 3.55 (s, 3 H). 13C NMR (100 MHz, DMSO-d6) δ: 153.8, 153.3,
130.3, 92.8, 60.1, 55.5. HRMS (ESI) Calcd for C9H11O4 [M − H]:
183.0663. Found: 183.0671. IR (neat cm−1) 3254, 1599, 1428, 1218,
1177, 1121, 990, 811, 777.
N,N-Diethyl-4-hydroxybenzamide (5d).35 Following general
procedure B, the title compound was prepared using 4-bromo-N,N-
diethylbenzamide (256 mg, 1.0 mmol); EtOAc/hexanes (3:1); 173
mg, 89%; pale-brown solid. m.p.: 121−123 °C (lit: 120 °C).35 1H
NMR (400 MHz, DMSO-d6) δ: 9.74 (br s, 1 H), 7.18 (d, J = 8.4 Hz, 2
H), 6.78 (d, J = 8.8 Hz, 2 H), 3.30 (br s, 4 H), 1.08 (t, J = 7.2 Hz, 6
H). 13C NMR (100 MHz, DMSO-d6) δ: 170.2, 158.2, 128.1, 127.7,
114.8, 13.5. HRMS (ESI) Calcd for C11H14NO2 [M − H]: 192.1030.
Found: 192.1039. IR (neat cm−1) 3076, 1570, 1434, 1361, 1316, 1277,
1244, 1170, 1101, 837, 764, 597.
4-Hydroxybenzophenone (5e).36 Following general procedure
B, the title compound was prepared using 4-bromobenzophenone
(261 mg, 1.0 mmol); EtOAc/hexanes (1:4); 196 mg, 99%; pale-brown
solid. m.p.: 133−134 °C (lit: 133.5−134.5 °C).36 1H NMR (400 MHz,
DMSO-d6) δ: 10.45 (br s, 1 H), 7.68−7.64 (ovrlp, 4 H), 7.62 (t, J =
7.2 Hz, 1 H), 7.52 (t, J = 7.2 Hz, 2 H), 6.90 (d, J = 8.4 Hz, 2 H). 13C
NMR (100 MHz, DMSO-d6) δ: 194.3, 162.0, 138.1, 132.5, 131.8,
129.1, 128.4, 127.9, 115.3. HRMS (ESI) Calcd for C13H9O2 [M − H]:
197.0608. Found: 197.0609. IR (neat cm−1) 3137, 1632, 1599, 1557,
1512, 1444, 1312, 1286, 1232, 1172, 1148, 939, 924, 848, 740, 694,
608.
4-Hydroxybenzonitrile (5f).37 Following general procedure B,
the title compound was prepared using 4-bromobenzonitrile (364 mg,
2.0 mmol, 2 equiv), 1 (68.4 mg, 0.08 mmol, 4 mol %), L5 (38.8 mg,
0.08 mmol, 4 mol %), aqueous CsOH solution [CsOH (900 mg, 6.0
mmol, 6 equiv) dissolved in deionized water (360 mg, 20.0 mmol, 20
equiv) as prepared in the preceding procedures], and 1,4-dioxane (4.0
mL); EtOAc/hexanes (1:2); 230 mg, 97%; pale-brown solid. m.p.:
109−110 °C (lit.: 111−112 °C).37 1H NMR (400 MHz, DMSO-d6) δ:
10.61 (br s, 1 H), 7.62 (d, J = 9.2 Hz, 2 H), 6.90 (d, J = 8.8 Hz, 2 H).
13C NMR (100 MHz, DMSO-d6) δ: 161.7, 134.2, 119.6, 116.4, 101.0.
HRMS (ESI) Calcd for C7H9N2O [M + NH4]: 137.0709. Found:
137.0709. IR (neat cm−1) 3263, 2230, 1585, 1507, 1438, 1365, 1281,
1219, 1165, 835, 750, 701.
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